Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BPTSNYSE:CCVNASDAQ:FWAANASDAQ:HCAQNYSE:WNW On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBPTSBiophytis$13.37$8.05▼$168.80$2.89M1.057,291 shs18,500 shsCCVChurchill Capital Corp V$10.40$10.39$9.90▼$11.00$283.58MN/A167,770 shs23,136 shsFWAAFifth Wall Acquisition Corp. I$1.11$12.40$9.77▼$12.92$39.46MN/A368,485 shs758,860 shsHCAQHealthCor Catalio Acquisition$0.80+10.3%$8.72$9.48▼$11.00$17.05MN/A114,974 shs408,654 shsWNWMeiwu Technology$1.81-4.1%$1.83$0.95▼$70.00$5.74M0.79628,807 shs20,491 shsA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBPTSBiophytis0.00%0.00%0.00%0.00%0.00%CCVChurchill Capital Corp V0.00%0.00%0.00%0.00%0.00%FWAAFifth Wall Acquisition Corp. I0.00%+19.30%+19.73%+3.74%-52.77%HCAQHealthCor Catalio Acquisition0.00%+7.87%-7.35%+15.81%-20.00%WNWMeiwu Technology0.00%+11.44%+13.39%+25.91%-87.53%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBPTSBiophytisN/AN/AN/AN/AN/AN/AN/AN/ACCVChurchill Capital Corp VN/AN/AN/AN/AN/AN/AN/AN/AFWAAFifth Wall Acquisition Corp. IN/AN/AN/AN/AN/AN/AN/AN/AHCAQHealthCor Catalio AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AWNWMeiwu TechnologyN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBPTSBiophytis 0.00N/AN/AN/ACCVChurchill Capital Corp V 0.00N/AN/AN/AFWAAFifth Wall Acquisition Corp. I 0.00N/AN/AN/AHCAQHealthCor Catalio Acquisition 0.00N/AN/AN/AWNWMeiwu Technology 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBPTSBiophytisN/AN/AN/AN/A($17.29) per shareN/ACCVChurchill Capital Corp VN/AN/A$1.94 per share5.36($1.68) per shareN/AFWAAFifth Wall Acquisition Corp. IN/AN/AN/AN/A$0.14 per shareN/AHCAQHealthCor Catalio AcquisitionN/AN/AN/AN/AN/AN/AWNWMeiwu Technology$158.49K36.22N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBPTSBiophytis-$18.43MN/A0.00N/AN/AN/AN/AN/AN/ACCVChurchill Capital Corp V$24.09MN/A0.00∞N/AN/A-30.29%2.28%N/AFWAAFifth Wall Acquisition Corp. IN/AN/A0.00∞N/AN/AN/AN/AN/AHCAQHealthCor Catalio AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AWNWMeiwu Technology-$16.07MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBPTSBiophytisN/AN/AN/AN/AN/ACCVChurchill Capital Corp VN/AN/AN/AN/AN/AFWAAFifth Wall Acquisition Corp. IN/AN/AN/AN/AN/AHCAQHealthCor Catalio AcquisitionN/AN/AN/AN/AN/AWNWMeiwu TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBPTSBiophytisN/A0.720.72CCVChurchill Capital Corp VN/A0.070.07FWAAFifth Wall Acquisition Corp. IN/A0.780.78HCAQHealthCor Catalio AcquisitionN/A0.480.48WNWMeiwu TechnologyN/A2.642.63Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBPTSBiophytis0.05%CCVChurchill Capital Corp V52.51%FWAAFifth Wall Acquisition Corp. I87.66%HCAQHealthCor Catalio Acquisition84.18%WNWMeiwu Technology0.29%Insider OwnershipCompanyInsider OwnershipBPTSBiophytis3.70%CCVChurchill Capital Corp V20.00%FWAAFifth Wall Acquisition Corp. IN/AHCAQHealthCor Catalio AcquisitionN/AWNWMeiwu TechnologyN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBPTSBiophytis22351,000338,000Not OptionableCCVChurchill Capital Corp V227.28 million21.82 millionNot OptionableFWAAFifth Wall Acquisition Corp. I235.55 millionN/ANot OptionableHCAQHealthCor Catalio Acquisition221.31 millionN/ANot OptionableWNWMeiwu Technology503.17 millionN/ANot OptionableWNW, HCAQ, BPTS, FWAA, and CCV HeadlinesRecent News About These CompaniesMeiwu Technology Company Limited Partners with Shenzhen Zhinuo Weichuang to Boost Brand Influence and Market Competitiveness - NasdaqJuly 3, 2025 | nasdaq.comMeiwu Technology Company Limited and Shenzhen Zhinuo Weichuang Technology Co., Ltd Form Strategic PartnershipJuly 1, 2025 | globenewswire.comMeiwu Falls on Shenzhen HookupJune 17, 2025 | baystreet.caMeiwu Technology Company Limited Collaborates with Shenzhen Zhinuo Weichuang to Enhance Brand Influence and Market CompetitivenessJune 17, 2025 | quiverquant.comQMeiwu Technology Company Limited and Shenzhen Zhinuoweichuang Technology Co., Ltd Form Strategic PartnershipJune 17, 2025 | globenewswire.comMeiwu Technology Delays 20-F FilingApril 30, 2025 | tipranks.comMeiwu Technology regains Nasdaq compliance with share priceApril 23, 2025 | investing.comMeiwu Technology Company regains compliance with NasdaqApril 22, 2025 | markets.businessinsider.comMeiwu Technology Company Limited Regains Compliance with Nasdaq Minimum Closing Bid Price RuleApril 21, 2025 | globenewswire.comMeiwu Technology Co Ltd trading halted, news pendingApril 1, 2025 | markets.businessinsider.comMeiwu Technology Company announces 1-for-20 reverse share splitMarch 29, 2025 | markets.businessinsider.comMeiwu Technology Company Limited Announces 1 for 20 Reverse Share SplitMarch 28, 2025 | globenewswire.comMeiwu Technology faces Nasdaq delisting over low share priceMarch 5, 2025 | investing.comMeiwu Technology Company receives noncompliance notification from NasdaqMarch 4, 2025 | markets.businessinsider.comMeiwu Technology Company Limited Receives Nasdaq Notification Regarding Minimum Bid Price Non-ComplianceMarch 3, 2025 | quiverquant.comQMeiwu Technology Company Limited Received Nasdaq Notification Letter Regarding Bid Price DeficiencyMarch 3, 2025 | globenewswire.comMeiwu Technology Co Ltd (WNW) Stock Dilemma: A Surge That Has Everyone Talking—What’s the Real Story?February 3, 2025 | bovnews.comBWhat’s Behind the -13.64% Drop in Meiwu Technology Co Ltd (WNW) Stock? Find Out Now!January 30, 2025 | bovnews.comBMeiwu Technology Co Ltd (WNW) Stock: A Deeper Look at Its True PotentialJanuary 11, 2025 | bovnews.comBMeiwu Technology - This May Be The Ground Floor????January 9, 2025 | msn.comWNW, HCAQ, BPTS, FWAA, and CCV Company DescriptionsBiophytis NASDAQ:BPTSBiophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is Sarconeos (BIO101), an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD), as well as in Phase 2/3 clinical study for the treatment of severe respiratory failure in patients suffering from COVID-19. It also develops Macuneos (BIO201), an orally administered small molecule for the treatment of retinal diseases, including dry age-related macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.Churchill Capital Corp V NYSE:CCVChurchill Capital Corp V does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as One Judith Acquisition Corp. Churchill Capital Corp V was incorporated in 2020 and is based in New York, New York.Fifth Wall Acquisition Corp. I NASDAQ:FWAAFifth Wall Acquisition Corp. I focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2020 and is based in Los Angeles, California.HealthCor Catalio Acquisition NASDAQ:HCAQHealthCor Catalio Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.Meiwu Technology NYSE:WNW$1.81 -0.08 (-4.13%) Closing price 03:59 PM EasternExtended Trading$1.78 -0.04 (-2.04%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Meiwu Technology Company Limited operates as an online and mobile commerce company in the People's Republic of China. It operates in three segments: Clean Food Platform, Restaurant, and others. The company offers green food, organic food, intangible cultural heritage food, agricultural products, and pollution-free products. It operates Clean Food Platform, an electronic online platform designs to provide primarily clean food to customers in China. The company also engages the provision of restaurant services; sells drinks, fruits, and frozen products; and wholesale of agricultural products, as well as provides short messages services and technical and consulting services. The company was formerly known as Wunong Net Technology Company Limited and changed its name to Meiwu Technology Company Limited in August 2021. Meiwu Technology Company Limited was founded in 2015 and is headquartered in Shenzhen, the People's Republic of China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
